Benjamin Shobert is the Founder and Managing Director of Seattle-based Rubicon Strategy Group, a boutique consulting firm specialized in market access work in China's healthcare, life science, and senior care industries. Rubicon also provides market entry and project management services for healthcare companies across Southeast Asia. In 2013, Rubicon completed the first syndicated research report on Myanmar's healthcare system. In September 2013, Ben became affiliated with the National Bureau of Asian Research (NBR) to advise on aging, healthcare reforms, and the pharmaceutical industry in China and Southeast Asia.

Shobert is a member of the National Committee on U.S.-China Relations and holds advisory board seats at Indiana University’s Research Center on Chinese Politics and Business as well as IAHSA-China. In 2012, he became a member of the Pacific Council on International Policy. For six years, he wrote a column for the Asia Times on U.S.-China trade and economic policy matters, with a particular focus on how relations between the two countries are being impacted post the 2008 financial crisis. Shobert's work has been featured at CNBC, China Business Review, Fortune Magazine (China), Harvard Asia Quarterly, and others. In late 2012, he became a new columnist at Forbes China and in 2013 began writing on aging and healthcare issues at Forbes. He is a contributor to the new book The Global Obama: Crossroads of Leadership in the 21st Century.

Last Updated: April 24, 2014

Sinica Podcast


Healthcare in China

Kaiser Kuo, Jeremy Goldkorn & more from Sinica Podcast
The state of healthcare in China is in many ways better than it was in the era of the barefoot doctors, with average life expectancy in the country now trailing the United States by only three years and morbidity rates far lower too. But while even...